DK158728C - Analogifremgangsmaade til fremstilling af triazolon-derivater - Google Patents

Analogifremgangsmaade til fremstilling af triazolon-derivater

Info

Publication number
DK158728C
DK158728C DK112582A DK112582A DK158728C DK 158728 C DK158728 C DK 158728C DK 112582 A DK112582 A DK 112582A DK 112582 A DK112582 A DK 112582A DK 158728 C DK158728 C DK 158728C
Authority
DK
Denmark
Prior art keywords
preparation
analogy procedure
triazolone derivatives
triazolone
derivatives
Prior art date
Application number
DK112582A
Other languages
Danish (da)
English (en)
Other versions
DK158728B (da
DK112582A (da
Inventor
Jr Davis L Temple
Jr Walter G Lobeck
Original Assignee
Bristol Myers Squibb Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=22922879&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK158728(C) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Bristol Myers Squibb Co filed Critical Bristol Myers Squibb Co
Publication of DK112582A publication Critical patent/DK112582A/da
Publication of DK158728B publication Critical patent/DK158728B/da
Application granted granted Critical
Publication of DK158728C publication Critical patent/DK158728C/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/06—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals
    • C07D295/067—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by halogen atoms or nitro radicals with the ring nitrogen atoms and the substituents attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/10—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/12—Oxygen or sulfur atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Biomedical Technology (AREA)
  • Public Health (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DK112582A 1981-03-16 1982-03-12 Analogifremgangsmaade til fremstilling af triazolon-derivater DK158728C (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US06/244,464 US4338317A (en) 1981-03-16 1981-03-16 Phenoxyethyl-1,2,4,-triazol-3-one antidepressants
US24446481 1981-03-16

Publications (3)

Publication Number Publication Date
DK112582A DK112582A (da) 1982-09-17
DK158728B DK158728B (da) 1990-07-09
DK158728C true DK158728C (da) 1990-12-03

Family

ID=22922879

Family Applications (1)

Application Number Title Priority Date Filing Date
DK112582A DK158728C (da) 1981-03-16 1982-03-12 Analogifremgangsmaade til fremstilling af triazolon-derivater

Country Status (26)

Country Link
US (1) US4338317A (it)
JP (1) JPS57159774A (it)
KR (1) KR880001374B1 (it)
AT (1) AT384022B (it)
BE (1) BE892503A (it)
CA (1) CA1198436A (it)
CH (1) CH649539A5 (it)
CY (1) CY1373A (it)
DE (1) DE3209557A1 (it)
DK (1) DK158728C (it)
ES (1) ES8305756A1 (it)
FI (1) FI73670C (it)
FR (1) FR2501690B1 (it)
GB (1) GB2096137B (it)
GR (1) GR76076B (it)
HK (1) HK4788A (it)
IE (1) IE52788B1 (it)
IT (1) IT1148137B (it)
KE (1) KE3711A (it)
LU (1) LU84011A1 (it)
MX (1) MX9203176A (it)
NL (2) NL190757C (it)
SE (1) SE447256B (it)
SG (1) SG30287G (it)
YU (1) YU43256B (it)
ZA (1) ZA821359B (it)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4487773A (en) * 1981-03-16 1984-12-11 Mead Johnson & Company 1,2,4-Triazol-3-one antidepressants
US4386091A (en) * 1982-02-24 1983-05-31 Mead Johnson & Company 2-Phenoxyalkyl-1,2,4-triazol-3-one antidepressants
AT388555B (de) * 1983-06-29 1989-07-25 Bristol Myers Co Verfahren zur herstellung von neuen 1,2,4-triazol-3-on-derivaten
US4575555A (en) * 1983-06-29 1986-03-11 Mead Johnson & Company 4-(3-Chlorophenyl)-1,2,3,6-tetrahydropyridine derivative
US4613600A (en) * 1983-09-30 1986-09-23 Mead Johnson & Company Antidepressant 1,2,4-triazolone compounds
YU44721B (en) * 1983-11-30 1990-12-31 Bristol Myers Co Process for obtaining 4-(2-phenoxyethyl)-1,2,4-triazolone
CA1248531A (en) * 1984-04-17 1989-01-10 Jeffrey C. Watkins 4-substituted piperazine-2-carboxylic acids
US4784998A (en) * 1987-04-06 1988-11-15 Bristol-Myers Company 1,3,4-oxadiazole pyschotropic compounds
US5116852A (en) * 1990-12-03 1992-05-26 Bristol-Myers Squibb Co. Treatment of sleep disorders
US5266571A (en) * 1992-01-09 1993-11-30 Amer Moh Samir Treatment of hemorrhoids with 5-HT2 antagonists
US5256664A (en) * 1992-04-28 1993-10-26 Bristol-Myers Squibb Company Antidepressant 3-halophenylpiperazinylpropyl derivatives of substituted triazolones and triazoldiones
IT1256387B (it) * 1992-11-13 1995-12-04 Acraf Procedimento per preparare triazoloni
CA2160423A1 (en) * 1994-11-02 1996-05-03 Hemant N. Joshi Salts of nefazodone having improved dissolution rates
AU7025396A (en) 1995-10-17 1997-05-01 Bristol-Myers Squibb Company Nefazodone: treatment of panic attack
CA2182241C (en) * 1996-07-29 2002-09-17 Bo Lei Methods for the manufacture of nefazodone
US5854248A (en) * 1996-07-31 1998-12-29 Bristol-Myers Squibb Company Nefazodone: use in migraine prophylaxis
US5852020A (en) * 1996-11-22 1998-12-22 Bristol-Myers Squibb Company Nefazodone: use in treating post traumatic stress disorder
US5735873A (en) * 1996-12-19 1998-04-07 Maclean; David S. Surgical tool handle
US5917050A (en) * 1998-02-11 1999-06-29 Bayer Corporation Process for preparing alkoxytriazolinones
ES2152860B1 (es) * 1998-10-23 2001-08-16 Finaf 92 Sa Forma cristalina de la nefazodona y procedimiento para su preparacion.
US6706282B1 (en) 1998-11-02 2004-03-16 Evangeline Cruz Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones
US6469008B2 (en) 1999-04-09 2002-10-22 Sepracor Inc. (R)-hydroxynefazodone antipsychotic therapy
AU4215400A (en) * 1999-04-09 2000-11-14 Sepracor, Inc. S-hydroxynefazodone
US6586437B2 (en) 1999-04-09 2003-07-01 Sepracor Inc. (S)-hydroxynefazodone antipsychotic therapy
CA2369732A1 (en) 1999-04-09 2000-10-19 Sepracor Inc. R-hydroxynefazodone
CA2356450C (en) 2001-09-10 2003-11-25 Brantford Chemicals Inc. An improved process for the preparation of nefazodone hydrochloride
US20050256131A1 (en) * 2002-05-24 2005-11-17 Carl-Fr Coester Pharmaceutical active substance combination and the use thereof
GB0306604D0 (en) * 2003-03-21 2003-04-30 Curidium Ltd Second medical use
CA2523191A1 (en) * 2003-04-30 2004-11-18 Fmc Corporation Phenyl substituted cyclic derivatives
ATE473967T1 (de) * 2003-11-26 2010-07-15 Pfizer Prod Inc Aminopyrazolderivate als gsk-3-inhibitoren
EP1737473A4 (en) * 2004-04-19 2009-08-26 Noven Therapeutics Llc COMBINATIONS OF LITHIUM AND USES THEREOF
TW200612961A (en) * 2004-05-18 2006-05-01 Fmc Corp Substituted cyclic urea derivatives
EP1904843A2 (en) * 2005-07-08 2008-04-02 Braincells, Inc. Methods for identifying agents and conditions that modulate neurogenesis
US7985756B2 (en) 2005-10-21 2011-07-26 Braincells Inc. Modulation of neurogenesis by PDE inhibition
US20070112017A1 (en) 2005-10-31 2007-05-17 Braincells, Inc. Gaba receptor mediated modulation of neurogenesis
US20100216734A1 (en) 2006-03-08 2010-08-26 Braincells, Inc. Modulation of neurogenesis by nootropic agents
JP2009536669A (ja) 2006-05-09 2009-10-15 ブレインセルス，インコーポレイティド アンジオテンシン調節による神経新生
MX2008014320A (es) 2006-05-09 2009-03-25 Braincells Inc Neurogenesis mediada por el receptor de 5-hidroxitriptamina.
US7858611B2 (en) * 2006-05-09 2010-12-28 Braincells Inc. Neurogenesis by modulating angiotensin
AU2007292848A1 (en) 2006-09-08 2008-03-13 Braincells, Inc. Combinations containing a 4-acylaminopyridine derivative
US20100184806A1 (en) 2006-09-19 2010-07-22 Braincells, Inc. Modulation of neurogenesis by ppar agents
US20080167363A1 (en) * 2006-12-28 2008-07-10 Braincells, Inc Modulation of Neurogenesis By Melatoninergic Agents
CA2675132A1 (en) * 2007-01-11 2008-07-17 Braincells, Inc. Modulation of neurogenesis with use of modafinil
GB2454290B (en) * 2007-08-07 2009-09-30 Prosarix Ltd Novel serotonergic modulators
WO2009111031A2 (en) 2008-03-04 2009-09-11 Intra-Cellular Therapies, Inc. Methods of treating vasomotor symptoms
EP2288345B1 (en) 2008-04-18 2015-06-10 University College Dublin National University Of Ireland, Dublin Psycho-pharmaceuticals
US20100216805A1 (en) 2009-02-25 2010-08-26 Braincells, Inc. Modulation of neurogenesis using d-cycloserine combinations
TWI368512B (en) * 2009-04-30 2012-07-21 Univ Kaohsiung Medical Pharmaceutical compositions comprising chlorophenyl piperazine derived compounds and use of the compounds in producing medicaments
WO2012072665A1 (en) 2010-11-30 2012-06-07 Pharmaneuroboost N.V. Compositions comprising pipamperone and serotonin antagonist reuptake inhibitors
CN104402842A (zh) * 2014-11-19 2015-03-11 苏州乔纳森新材料科技有限公司 一种哌嗪类药物中间体的合成方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IT1066857B (it) * 1965-12-15 1985-03-12 Acraf Derivati della s ipiazolo 4.3 a piridina e processi per la loro preparazione
IT1052119B (it) * 1972-10-16 1981-06-20 Sigma Tau Ind Farmaceuti Derivati del triazolinone e procedimento per la loro preparazione

Also Published As

Publication number Publication date
SE8201631L (sv) 1982-09-17
DK158728B (da) 1990-07-09
IE52788B1 (en) 1988-03-02
HK4788A (en) 1988-01-29
IE820589L (en) 1982-09-16
NL970014I1 (nl) 1997-06-02
MX9203176A (es) 1992-07-01
FI73670B (fi) 1987-07-31
ZA821359B (en) 1983-01-26
DE3209557C2 (it) 1993-07-15
FR2501690A1 (fr) 1982-09-17
AT384022B (de) 1987-09-25
ES510449A0 (es) 1983-04-16
US4338317A (en) 1982-07-06
YU52582A (en) 1985-06-30
KR830009089A (ko) 1983-12-17
NL970014I2 (nl) 1997-09-01
CH649539A5 (de) 1985-05-31
NL190757C (nl) 1994-08-01
DK112582A (da) 1982-09-17
NL190757B (nl) 1994-03-01
LU84011A1 (fr) 1983-02-22
AU8117082A (en) 1982-09-23
GB2096137A (en) 1982-10-13
KE3711A (en) 1987-04-30
JPS57159774A (en) 1982-10-01
SG30287G (en) 1987-07-17
DE3209557A1 (de) 1982-12-09
GB2096137B (en) 1985-01-03
FI820856L (fi) 1982-09-17
FR2501690B1 (fr) 1985-07-05
GR76076B (it) 1984-08-03
BE892503A (fr) 1982-09-15
IT1148137B (it) 1986-11-26
IT8247978A0 (it) 1982-03-12
YU43256B (en) 1989-06-30
KR880001374B1 (ko) 1988-07-29
ATA104582A (de) 1987-02-15
JPH0237353B2 (it) 1990-08-23
NL8201021A (nl) 1982-10-18
ES8305756A1 (es) 1983-04-16
SE447256B (sv) 1986-11-03
CA1198436A (en) 1985-12-24
AU555888B2 (en) 1986-10-16
FI73670C (fi) 1987-11-09
CY1373A (en) 1987-08-07

Similar Documents

Publication Publication Date Title
DK158728C (da) Analogifremgangsmaade til fremstilling af triazolon-derivater
DK149949C (da) Analogifremgangsmaade til fremstilling af n-aryl-piperazinalkanamider
DK157876C (da) Analogifremgangsmaade til fremstilling af imidazo-rifamycin-derivater
DK155282C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK66582A (da) Fremgangsmaade til fremstilling af carbostyrilderivater
DK65882A (da) Fremgangsmaade til fremstilling af substituerede phosphonamider
DK162524C (da) Analogifremgangsmaade til fremstilling af 5-alkylthio-tetrazolderivater
DK491582A (da) Fremgangsmaade til fremstilling af morphinanderivater
DK162991C (da) Analogifremgangsmaade til fremstilling af thiazolidinylalkylenpiperazinderivater
DK352082A (da) Fremgangsmaade til fremstilling af ergopeptinderivater
DK453882A (da) Fremgangsmaade til fremstilling af triazinderivater
DK162167C (da) Analogifremgangsmaade til fremstilling af mitosanderivater
DK153282A (da) Fremgangsmaade til fremstilling af bismethinisoindoliner
DK127482A (da) Fremgangsmaade til fremstilling af dipeptidforbindelser
DK150070C (da) Analogifremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater
DK239382A (da) Fremgangsmaade til fremstilling af anthracyclinglycosider
DK160555C (da) Fremgangsmaade til fremstilling af eburnamoninderivater
DK305982A (da) Fremgangsmaade til fremstilling af amidobenzamider
DK116982A (da) Fremgangsmaade til fremstilling af alkylendioxybenzenderivater
DK156722C (da) Analogifremgangsmaade til fremstilling af 2-piperazinopyrimidinderivater
DK151956C (da) Analogifremgangsmaade til fremstilling af carbostyrilderivater
DK162230C (da) Fremgangsmaade til fremstilling af 2-thiacephemderivater
DK375882A (da) Fremgangsmaade til fremstilling af benzisoxazolderivater
DK157873C (da) Analogifremgangsmaade til fremstilling af azinorifamycin-forbindelser
DK156219C (da) Analogifremgangsmaade til fremstilling af spirothiazolidinylpiperazinderivater

Legal Events

Date Code Title Description
CTFF Application for supplementary protection certificate (spc) filed

Free format text: CA 1997 00025, 970708

CTFG Supplementary protection certificate (spc) issued

Free format text: CA 1997 00025, 970708, EXPIRES: 20070312

PUP Patent expired